Rapid evaluation of 25 key sphingolipids and phosphosphingolipids in human plasma by LC-MS/MS

Analytical and Bioanalytical Chemistry

Volumn 407, Issue 17, 2015, Pages 5189-5198

  Basit, Abdul ^a   Piomelli, Daniele ^a,b   Armirotti, Andrea ^a  

^a ISTITUTO ITALIANO DI TECNOLOGIA   (Italy)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Ceramides; Human plasma; LC MS MS; Sphinganine 1 phosphate; Sphingomyelins; Sphingosine 1 phosphate

Indexed keywords

ALKANOLAMINES; CERAMIDES; COST EFFECTIVENESS; LIPIDS; SPHINGOSINES;

HUMAN PLASMAS; LC-MS/MS; SPHINGANINE; SPHINGOMYELINS; SPHINGOSINE;

PLASMA (HUMAN);

PHOSPHOLIPID; SPHINGOLIPID;

BLOOD; ECONOMICS; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LIMIT OF DETECTION; LIQUID LIQUID EXTRACTION; MALE; PROCEDURES; REPRODUCIBILITY; REVERSED PHASE LIQUID CHROMATOGRAPHY; TANDEM MASS SPECTROMETRY; VALIDATION STUDY;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHROMATOGRAPHY, REVERSE-PHASE; FEMALE; HUMANS; LIMIT OF DETECTION; LIQUID-LIQUID EXTRACTION; MALE; PHOSPHOLIPIDS; REPRODUCIBILITY OF RESULTS; SPHINGOLIPIDS; TANDEM MASS SPECTROMETRY;

EID: 84924266259     PISSN: 16182642     EISSN: 16182650     Source Type: Journal    
DOI: 10.1007/s00216-015-8585-6     Document Type: Article

References (45)

1. Webb LM, Arnholt AT, Venable ME (2010) Phospholipase D modulation by ceramide in senescence.Mol Cell Biochem 337(1-2):153-158
2. Teichgräber V, Ulrich M, Endlich N, Riethmüller J, Wilker B, De Oliveira-Munding CC, van Heeckeren AM, Barr ML, von Kürthy G, Schmid KW, Weller M, Tümmler B, Lang F, Grassme H, Döring G, Gulbins E (2008) Ceramide accumulation mediates inflammation, cell death and infection susceptibility in cystic fibrosis. Nat Med 14(4):382-391
3. Posse de Chaves EI (2006) Sphingolipids in apoptosis, survival and regeneration in the nervous system. BiochimBiophys Acta 1758(12):1995-2015
4. Young MM, Kester M, Wang HG (2013) Sphingolipids: regulators of crosstalk between apoptosis and autophagy. J Lipid Res 54(1):5-19
5. He X, Huang Y, Li B, Gong CX, Schuchman EH (2010) Deregulation of sphingolipid metabolism in Alzheimer’s disease. Neurobiol Aging 31(3):398-408
6. Mielke MM, Haughey NJ, Bandaru VV, Weinberg DD, Darby E, Zaidi N, Pavlik V, Doody RS, Lyketsos CG (2011) Plasma sphingomyelins are associated with cognitive progression in Alzheimer’s disease. J Alzheimers Dis 27(2):259-269
7. Mielke MM, Haughey NJ, Ratnam Bandaru VV, Schech S, Carrick R, Carlson MC, Mori S, Miller MI, Ceritoglu C, Brown T, Albert M, Lyketsos CG (2010) Plasma ceramides are altered in mild cognitive impairment and predict cognitive decline and hippocampal volume loss. Alzheimers Dement 6(5):378-385
8. Bieberich E (2008) Ceramide signaling in cancer and stem cells. Futur Lipidol 3(3):273-300
9. Haus JM, Kashyap SR, Kasumov T, Zhang R, Kelly KR, Defronzo RA, Kirwan JP (2009) Plasma ceramides are elevated in obese subjects with type 2 diabetes and correlate with the severity of insulin resistance. Diabetes 58(2):337-343
10. Farwanah H, Pierstorff B, Schmelzer CE, Raith K, Neubert RH, Kolter T, Sandhoff K (2007) Separation andmass spectrometric characterization of covalently bound skin ceramides using LC/APCI-MS and Nano-ESI-MS/MS. J Chromatogr B Anal Technol Biomed Life Sci 852(1-2):562-570
11. Bismuth J, Lin P, Yao Q, Chen C (2008) Ceramide: a common pathway for atherosclerosis? Atherosclerosis 196(2):497-504
12. Samad F, Hester KD, Yang G, Hannun YA, Bielawski J (2006) Altered adipose and plasma sphingolipid metabolism in obesity: a potential mechanism for cardiovascular and metabolic risk. Diabetes 55(9):2579-2587
13. Kitatani K, Idkowiak-Baldys J, Hannun YA (2008) The sphingolipid salvage pathway in ceramide metabolism and signaling. Cell Signal 20(6):1010-1018
14. Hanson MA, Roth CB, Jo E, Griffith MT, Scott FL, Reinhart G, Desale H, Clemons B, Cahalan SM, Schuerer SC, Sanna MG, Han GW, Kuhn P, Rosen H, Stevens RC (2012) Crystal structure of a lipid G protein-coupled receptor. Science 335(6070):851-855
15. Park SW, Kim M, Chen SW, Brown KM, D’Agati VD, Lee HT (2010) Sphinganine-1-phosphate protects kidney and liver after hepatic ischemia and reperfusion in mice through S1P1 receptor activation. Lab Investig 90(8):1209-1224
16. Bruce CR, Thrush AB, Mertz VA, Bezaire V, Chabowski A, Heigenhauser GJ, Dyck DJ (2006) Endurance training in obese humans improves glucose tolerance and mitochondrial fatty acid oxidation and alters muscle lipid content. Am J Physiol Endocrinol Metab 291(1):E99-E107
17. Yano M, Kishida E, Muneyuki Y, Masuzawa Y (1998) Quantitative analysis of ceramide molecular species by high performance liquid chromatography. J Lipid Res 39(10):2091-2098
18. Lee S, Lee YS, Choi KM, Yoo KS, Sin DM, Kim W, Lee YM, Hong JT, Yun YP, Yoo HS (2012) Quantitative analysis of sphingomyelin by high-performance liquid chromatography after enzymatic hydrolysis. Evid Based Complement Alternat Med 2012:396218
19. Cowart LA, Szulc Z, Bielawska A, Hannun YA (2002) Structural determinants of sphingolipid recognition by commercially available anti-ceramide antibodies. J Lipid Res 43(12):2042-2048
20. Liou YB, Sheu MT, Liu DZ, Lin SY, Ho HO (2010) Quantitation of ceramides in nude mouse skin by normal-phase liquid chromatography and atmospheric pressure chemical ionization mass spectrometry. Anal Biochem 401(1):107-113
21. Thomas D, Eberle M, Schiffmann S, Zhang DD, Geisslinger G, Ferreiros N (2013) Nano-LC-MS/MS for the quantitation of ceramides in mice cerebrospinal fluid using minimal sample volume. Talanta 116:912-918
22. Kasumov T, Huang H, Chung YM, Zhang R, McCullough AJ, Kirwan JP (2010) Quantification of ceramide species in biological samples by liquid chromatography electrospray ionization tandem mass spectrometry. Anal Biochem 401(1):154-161
23. Jiang H, Hsu FF, Farmer MS, Peterson LR, Schaffer JE, Ory DS, Jiang X (2013) Development and validation of LC-MS/MS method for determination of very long acyl chain (C22:0 and C24:0) ceramides in human plasma. Anal Bioanal Chem 405(23):7357-7365
24. Farwanah H, Kolter T, Sandhoff K (2011) Mass spectrometric analysis of neutral sphingolipids: methods, applications, and limitations. Biochim Biophys Acta 1811(11):854-860
25. Bui HH, Leohr JK, Kuo MS (2012) Analysis of sphingolipids in extracted human plasma using liquid chromatography electrospray ionization tandem mass spectrometry. Anal Biochem 423(2):187-194
26. Eisinger K, Krautbauer S, Hebel T, Schmitz G, Aslanidis C, Liebisch G, Buechler C (2014) Lipidomic analysis of the liver from high-fat diet induced obese mice identifies changes in multiple lipid classes. Exp Mol Pathol 97(1):37-43
27. Schuhmann K, Almeida R, Baumert M, Herzog R, Bornstein SR, Shevchenko A (2012) Shotgun lipidomics on a LTQ Orbitrap mass spectrometer by successive switching between acquisition polarity modes. J Mass Spectrom 47(1):96-104
28. Legnini E, Orsini JJ, Muhl A, Johnson B, Dajnoki A, Bodamer OA (2012) Analysis of acid sphingomyelinase activity in dried blood spots using tandem mass spectrometry. Ann LabMed 32(5):319-323
29. Sanchez BA, Capote FP, Luque de Castro MD (2011) Targeted analysis of sphingoid precursors in human biofluids by solid-phase extraction with in situ derivatization prior to mu-LC-LIF determination. Anal Bioanal Chem 400(3):757-765
30. Bligh EG, Dyer WJ (1959) A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37(8):911-917
31. Palmer K, Di Iulio F, Varsi AE, Gianni W, Sancesario G, Caltagirone C, Spalletta G (2010) Neuropsychiatric predictors of progression from amnestic-mild cognitive impairment to Alzheimer’s disease:the role of depression and apathy. J Alzheimers Dis 20(1):175-183
32. Di Iulio F, Palmer K, Blundo C, Casini AR, Gianni W, Caltagirone C, Spalletta G (2010) Occurrence of neuropsychiatric symptoms and psychiatric disorders in mild Alzheimer’s disease and mild cognitive impairment subtypes. Int Psychogeriatr 22(4):629-640
33. Gu H, Liu G, Wang J, Aubry AF, Arnold ME (2014) Selecting the correct weighting factors for linear and quadratic calibration curves with least-squares regression algorithm in bioanalytical LC-MS/MS assays and impacts of using incorrect weighting factors on curve stability, data quality, and assay performance. Anal Chem 86(18):8959-8966
34. van deMerbel NC (2008) Quantitative determination of endogenous compounds in biological samples using chromatographic techniques. Trends Anal Chem 27(10):924-933
35. Booth B, Arnold ME, DeSilva B, Amaravadi L, Dudal S, Fluhler E, Gorovits B, Haidar SH, Kadavil J, Lowes S, Nicholson R, Rock M, Skelly M, Stevenson L, Subramaniam S, Weiner R,Woolf E. (2014) Workshop report: crystal city V-Quantitative bioanalytical method validation and implementation: the 2013 revised FDA guidance. AAPS journal. doi:10.1208/s12248-014-9696-2
36. Matuszewski BK, Constanzer ML, Chavez-Eng CM (2003) Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS. Anal Chem 75(13):3019-3030
37. Lan T, Bi H, Liu W, Xie X, Xu S, Huang H (2011) Simultaneous determination of sphingosine and sphingosine 1-phosphate in biological samples by liquid chromatography-tandem mass spectrometry. J Chromatogr B Anal Technol Biomed Life Sci 879(7-8):520-526
38. Shaner RL, Allegood JC, Park H, Wang E, Kelly S, Haynes CA, Sullards MC, Merrill AH Jr (2009) Quantitative analysis of sphingolipids for lipidomics using triple quadrupole and quadrupole linear ion trap mass spectrometers. J Lipid Res 50(8):1692-1707
39. Byrdwell WC, Perry RH (2006) Liquid chromatography with dual parallel mass spectrometry and (31)P nuclear magnetic resonance spectros copy for analysis of sphi ngomye l i n and dihydrosphingomyelin I. Bovine brain and chicken egg yolk. J Chromatogr A 1133(1-2):149-171
40. Geis-Asteggiante L, Lehotay SJ, Lightfield AR, Dutko T, Ng C, Bluhm L (2012) Ruggedness testing and validation of a practical analyticalmethod for >100 veterinary drug residues in bovinemuscle by ultrahigh performance liquid chromatography-tandem mass spectrometry. J Chromatogr A 1258:43-54
41. Evseenko D, Latour B, Richardson W, Corselli M, Sahaghian A, Cardinal S, Zhu Y, Chan R, Dunn B, Crooks GM (2013) Lysophosphatidic acid mediates myeloid differentiation within the human bone marrow microenvironment. PLoS One 8(5):e63718
42. Chen RF (1967) Removal of fatty acids from serum albumin by charcoal treatment. J Biol Chem 242(2):173-181
43. Jones BR, Schultz GA, Eckstein JA, Ackermann BL (2012) Surrogate matrix and surrogate analyte approaches for definitive quantitation of endogenous biomolecules. Bioanalysis 4(19):2343-2356
44. Chen S,Wu JT, Huang R (2012) Evaluation of surrogate matrices for standard curve preparation in tissue bioanalysis. Bioanalysis 4(21):2579-2587
45. Bowen CL, Kehler J, Evans CA (2010) Development and validation of a sensitive and selective UHPLC-MS/MS method for simultaneous determination of both free and total eicosapentaeonic acid and docosahexenoic acid in human plasma. J Chromatogr B Anal Technol Biomed Life Sci 878(30):3125-3133